Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Hepatology

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2010.01.036PMID 20447718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997–2006

  2009cited by this paper
• A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland

  2009cited by this paper
• The many faces of hepatitis C: Liver disease and type 2 diabetes

  2009cited by this paper
• Chronic liver disease--an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease.

  2008cited by this paper
• A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland

  2008cited by this paper
• Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community‐based register study

  2008cited by this paper
• Drug use and risk among regular injecting drug users in Australia: does age make a difference?

  2008cited by this paper
• The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.

  2008cited by this paper
• Modelling the hepatitis C virus epidemic in Australia.

  2007cited by this paper
• Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.

  2006cited by this paper
• Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.

  2006cited by this paper
• Mortality in patients with hepatitis B or hepatitis C: authors' reply

  2006cited by this paper
• Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

  2006cited by this paper
• Mortality in patients with hepatitis B or hepatitis C.

  2006cited by this paper
• Trends in health care resource use for hepatitis C virus infection in the United States

  2005cited by this paper
• Non‐Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection

  2005cited by this paper
• Effects of a sustained heroin shortage in three Australian States.

  2005cited by this paper
• High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.

  2004cited by this paper
• Hepatitis B and C virus infection and the risk of atherosclerosis in a general population.

  2004cited by this paper
• Hepatitis C and renal disease: an update.

  2003cited by this paper
• Decreased heroin availability in Sydney in early 2001.

  2003cited by this paper
• Essential Medical Statistics

  2003cited by this paper
• Epidemiology and economic burden of viral hepatitis: an observational population based study

  2002cited by this paper
• Health care, treatment patterns and cost of services for patients infected with chronic hepatitis C virus in a large insured New England population

  2000cited by this paper
• EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.

  1999cited by this paper
• Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

  1999cited by this paper
• Modelling the hepatitis C virus epidemic in Australia

  1999influential reference
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• Standardized rates of recurrent outcomes.

  1994cited by this paper

• Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review

  2024cites this paper
• Five‐year conditional survival for patients with hepatocellular carcinoma in Queensland, Australia

  2019cites this paper
• Safety and Economic Evaluation of Patients Treated for Hepatitis with Antiviral Daclatasvir and Sofosbuvir Combined Vs. Ledipasvir/ Sofosbuvir 90mg/400mg in a medical institution in The U.A.E

  2018cites this paper
• Use of data linkage to improve communicable disease surveillance and control in Australia: existing practices, barriers and enablers

  2018cites this paper
• The Prevalence of Hepatitis C Virus Core Amino Acid 70 Substitution and Genotypes of Polymorphisms Near the IFNL3 Gene in Iranian Patients With Chronic Hepatitis C

  2016cites this paper
• The progression and management of depression and anxiety in chronic hepatitis C patients.

  2015cites this paper
• Impact of physical and psychological factors on health‐related quality of life in adult patients with liver cirrhosis: a systematic review protocol

  2015cites this paper
• The IFN-λ Genetic Polymorphism Association With the Viral Clearance Induced by Hepatitis C Virus Treatment in Pakistani Patients

  2014cites this paper
• Delivery of treatment for hepatitis C virus infection in the primary care setting

  2014cites this paper
• Strategies to manage hepatitis C virus (HCV) disease burden

  2014cites this paper
• Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

  2014cites this paper
• Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C‐related liver disease and costs in Australia

  2014cites this paper
• A Comparison of Risk Factors for Hepatitis C Among Young and Older Adult Prisoners

  2014cites this paper
• HCV burden in Europe and the possible impact of current treatment.

  2013cites this paper
• A study of the natural history of hepatitis C infection within a geographically determined population (Trent HCV study)

  2012cites this paper
• Natural history of acute and chronic hepatitis C.

  2012cites this paper
• The influence of hepatitis C and alcohol on liver‐related morbidity and mortality in Glasgow’s injecting drug user population

  2011cites this paper
• Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study

  2011cites this paper
• The Centre for Health Record Linkage: fostering population health research in NSW.

  2011cites this paper
• Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C

  2010cites this paper